OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Synthesis of [11C]HG-10-102-01 as a new potential PET agent for imaging of LRRK2 enzyme in Parkinson’s disease
Min Wang, Mingzhang Gao, Zhidong Xu, et al.
Bioorganic & Medicinal Chemistry Letters (2017) Vol. 27, Iss. 6, pp. 1351-1355
Open Access | Times Cited: 17
Min Wang, Mingzhang Gao, Zhidong Xu, et al.
Bioorganic & Medicinal Chemistry Letters (2017) Vol. 27, Iss. 6, pp. 1351-1355
Open Access | Times Cited: 17
Showing 17 citing articles:
LRRK2 in Parkinson disease: challenges of clinical trials
Eduardo Tolosa, Miquel Vila, Christine Klein, et al.
Nature Reviews Neurology (2020) Vol. 16, Iss. 2, pp. 97-107
Closed Access | Times Cited: 371
Eduardo Tolosa, Miquel Vila, Christine Klein, et al.
Nature Reviews Neurology (2020) Vol. 16, Iss. 2, pp. 97-107
Closed Access | Times Cited: 371
The role of neuroimaging in Parkinson’s disease
Natasha Bidesi, Ida Vang Andersen, Albert D. Windhorst, et al.
Journal of Neurochemistry (2021) Vol. 159, Iss. 4, pp. 660-689
Open Access | Times Cited: 88
Natasha Bidesi, Ida Vang Andersen, Albert D. Windhorst, et al.
Journal of Neurochemistry (2021) Vol. 159, Iss. 4, pp. 660-689
Open Access | Times Cited: 88
The Current State-of-the Art of LRRK2-Based Biomarker Assay Development in Parkinson’s Disease
Hardy J. Rideout, Marie‐Christine Chartier‐Harlin, Matthew Fell, et al.
Frontiers in Neuroscience (2020) Vol. 14
Open Access | Times Cited: 39
Hardy J. Rideout, Marie‐Christine Chartier‐Harlin, Matthew Fell, et al.
Frontiers in Neuroscience (2020) Vol. 14
Open Access | Times Cited: 39
Radiotracers for imaging of Parkinson's disease
Nasrin Abbasi Gharibkandi, Seyed Jalal Hosseinimehr
European Journal of Medicinal Chemistry (2019) Vol. 166, pp. 75-89
Closed Access | Times Cited: 32
Nasrin Abbasi Gharibkandi, Seyed Jalal Hosseinimehr
European Journal of Medicinal Chemistry (2019) Vol. 166, pp. 75-89
Closed Access | Times Cited: 32
Imaging Leucine-Rich Repeat Kinase 2 In Vivo with 18F-Labeled Positron Emission Tomography Ligand
Zhen Chen, Jiahui Chen, Laigao Chen, et al.
Journal of Medicinal Chemistry (2022) Vol. 66, Iss. 3, pp. 1712-1724
Closed Access | Times Cited: 17
Zhen Chen, Jiahui Chen, Laigao Chen, et al.
Journal of Medicinal Chemistry (2022) Vol. 66, Iss. 3, pp. 1712-1724
Closed Access | Times Cited: 17
Preclinical Evaluation of Novel Positron Emission Tomography (PET) Probes for Imaging Leucine-Rich Repeat Kinase 2 (LRRK2)
Zhen Chen, Jiahui Chen, Wakana Mori, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 4, pp. 2559-2569
Open Access | Times Cited: 3
Zhen Chen, Jiahui Chen, Wakana Mori, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 4, pp. 2559-2569
Open Access | Times Cited: 3
PET imaging in animal models of Parkinson’s disease
Ruiqing Ni
Behavioural Brain Research (2022) Vol. 438, pp. 114174-114174
Open Access | Times Cited: 10
Ruiqing Ni
Behavioural Brain Research (2022) Vol. 438, pp. 114174-114174
Open Access | Times Cited: 10
Synthesis and preliminary biological evaluation of radiolabeled 5-BDBD analogs as new candidate PET radioligands for P2X4 receptor
Min Wang, Mingzhang Gao, Jill A. Meyer, et al.
Bioorganic & Medicinal Chemistry (2017) Vol. 25, Iss. 14, pp. 3835-3844
Open Access | Times Cited: 16
Min Wang, Mingzhang Gao, Jill A. Meyer, et al.
Bioorganic & Medicinal Chemistry (2017) Vol. 25, Iss. 14, pp. 3835-3844
Open Access | Times Cited: 16
Synthesis and Preliminary Evaluation of [11C]GNE‐1023 as a Potent PET Probe for Imaging Leucine‐Rich Repeat Kinase 2 (LRRK2) in Parkinson's Disease
Zhen Chen, Tuo Shao, Wei Gao, et al.
ChemMedChem (2019) Vol. 14, Iss. 17, pp. 1580-1585
Open Access | Times Cited: 14
Zhen Chen, Tuo Shao, Wei Gao, et al.
ChemMedChem (2019) Vol. 14, Iss. 17, pp. 1580-1585
Open Access | Times Cited: 14
Synthesis and preliminary biological evaluation of [11C]methyl (2-amino-5-(benzylthio)thiazolo[4,5-d]pyrimidin-7-yl)-d-leucinate for the fractalkine receptor (CX3CR1)
Mingzhang Gao, Min Wang, Jill A. Meyer, et al.
Bioorganic & Medicinal Chemistry Letters (2017) Vol. 27, Iss. 12, pp. 2727-2730
Open Access | Times Cited: 13
Mingzhang Gao, Min Wang, Jill A. Meyer, et al.
Bioorganic & Medicinal Chemistry Letters (2017) Vol. 27, Iss. 12, pp. 2727-2730
Open Access | Times Cited: 13
Metal complexes for multimodal imaging of misfolded protein-related diseases
Sara Lacerda, Jean‐François Morfin, Carlos F. G. C. Geraldes, et al.
Dalton Transactions (2017) Vol. 46, Iss. 42, pp. 14461-14474
Open Access | Times Cited: 12
Sara Lacerda, Jean‐François Morfin, Carlos F. G. C. Geraldes, et al.
Dalton Transactions (2017) Vol. 46, Iss. 42, pp. 14461-14474
Open Access | Times Cited: 12
18F-Labelled pyrrolopyrimidines reveal brain leucine-rich repeat kinase 2 expression implicated in Parkinson’s disease
Xueyuan Chen, Qiuyang Zhang, Yunming Zhang, et al.
European Journal of Medicinal Chemistry (2021) Vol. 214, pp. 113245-113245
Closed Access | Times Cited: 10
Xueyuan Chen, Qiuyang Zhang, Yunming Zhang, et al.
European Journal of Medicinal Chemistry (2021) Vol. 214, pp. 113245-113245
Closed Access | Times Cited: 10
Evaluation of [18F]PF-06455943 as a Potential LRRK2 PET Imaging Agent in the Brain of Nonhuman Primates
Chi‐Hyeon Yoo, Zhen Chen, Nisha Rani, et al.
ACS Chemical Neuroscience (2023) Vol. 14, Iss. 3, pp. 370-377
Closed Access | Times Cited: 3
Chi‐Hyeon Yoo, Zhen Chen, Nisha Rani, et al.
ACS Chemical Neuroscience (2023) Vol. 14, Iss. 3, pp. 370-377
Closed Access | Times Cited: 3
Synthesis of carbon-11-labeled 5-HT6R antagonists as new candidate PET radioligands for imaging of Alzheimer’s disease
Xiaohong Wang, Fugui Dong, Caihong Miao, et al.
Bioorganic & Medicinal Chemistry Letters (2018) Vol. 28, Iss. 10, pp. 1836-1841
Open Access | Times Cited: 7
Xiaohong Wang, Fugui Dong, Caihong Miao, et al.
Bioorganic & Medicinal Chemistry Letters (2018) Vol. 28, Iss. 10, pp. 1836-1841
Open Access | Times Cited: 7
Synthesis of carbon-11-labeled CK1 inhibitors as new potential PET radiotracers for imaging of Alzheimer’s disease
Mingzhang Gao, Min Wang, Qi-Huang Zheng
Bioorganic & Medicinal Chemistry Letters (2018) Vol. 28, Iss. 13, pp. 2234-2238
Open Access | Times Cited: 7
Mingzhang Gao, Min Wang, Qi-Huang Zheng
Bioorganic & Medicinal Chemistry Letters (2018) Vol. 28, Iss. 13, pp. 2234-2238
Open Access | Times Cited: 7
Radiosynthesis and evaluation of 4-(6-[18F]Fluoro-4-(5-isopropoxy-1H-indazol-3-yl)pyridin-2-yl)morpholine as a novel radiotracer candidate targeting leucine-rich repeat kinase 2
Wakana Mori, Tomoteru Yamasaki, Yasushi Hattori, et al.
RSC Medicinal Chemistry (2020) Vol. 11, Iss. 6, pp. 676-684
Open Access | Times Cited: 3
Wakana Mori, Tomoteru Yamasaki, Yasushi Hattori, et al.
RSC Medicinal Chemistry (2020) Vol. 11, Iss. 6, pp. 676-684
Open Access | Times Cited: 3
Exploring natural compound, Panicutine as leucine-rich repeat kinase 2 inhibitor against Parkinson’s disease: a structure-guided approach
Taghreed A. Majrashi, Shadma Wahab, Mohammad Ali Abdullah Almoyad, et al.
Journal of Biomolecular Structure and Dynamics (2023), pp. 1-10
Closed Access
Taghreed A. Majrashi, Shadma Wahab, Mohammad Ali Abdullah Almoyad, et al.
Journal of Biomolecular Structure and Dynamics (2023), pp. 1-10
Closed Access
